Daxor Revenue 2010-2011 | DXR

Daxor revenue from 2010 to 2011. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Daxor Annual Revenue
(Millions of US $)
2011 $1
2010 $2
2009 $2
Daxor Quarterly Revenue
(Millions of US $)
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.041B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.469B 19.19
Encompass Health (EHC) United States $12.181B 25.82
DaVita (DVA) United States $10.148B 14.27
Chemed (CHE) United States $8.345B 26.23
Elanco Animal Health (ELAN) United States $6.665B 14.28
Option Care Health (OPCH) United States $5.217B 23.25
RadNet (RDNT) United States $4.371B 277.43
Amedisys (AMED) United States $3.101B 20.86
LifeStance Health (LFST) United States $2.287B 0.00
Addus HomeCare (ADUS) United States $2.046B 22.47
Astrana Health (ASTH) United States $1.374B 34.03
U.S Physical Therapy (USPH) United States $1.127B 29.09
Aveanna Healthcare Holdings (AVAH) United States $1.067B 60.78
Pennant (PNTG) United States $0.994B 36.49
Atai Life Sciences (ATAI) Germany $0.499B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00